Terms: = Ovarian cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911
59 results:
1. A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
Komatsu H; Matsumoto K; Morita M; Nagasawa T; Nishio H; Suzuki J; Nishio S; Kobara H; Yunokawa M; Ariyoshi K; Hirayama T; Tokunaga H; Ukita M; Yoriki K; Mori-Uchino M; Furusawa A; Togami S; Nakamura H; Ishikawa M; Satoh T
Cancer Med; 2024 Mar; 13(5):e6968. PubMed ID: 38491829
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumors.
Iizuka M; Hamada Y; Matsushima J; Ichikawa T; Irie T; Yamaguchi N; Sakamoto S; Ban S; Takakura S
J Obstet Gynaecol Res; 2023 Nov; 49(11):2717-2727. PubMed ID: 37643727
[TBL] [Abstract] [Full Text] [Related]
3. Disparities in refusal of surgery for gynecologic cancer.
Samuel D; Kwon D; Huang M; Zhao W; Roy M; Tabuyo-Martin A; Siemon J; Schlumbrecht MP; Pearson JM; Sinno AK
Gynecol Oncol; 2023 Jul; 174():1-10. PubMed ID: 37141816
[TBL] [Abstract] [Full Text] [Related]
4. Molecular targets of metformin against ovarian cancer based on network pharmacology.
Guo JY; Wang YJ; Li SQ; Wu YP
Chem Biol Drug Des; 2023 Jul; 102(1):88-100. PubMed ID: 36977503
[TBL] [Abstract] [Full Text] [Related]
5. Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up.
Kotaniemi-Talonen L; Pukkala E; Aittomäki K; Auranen A
Acta Obstet Gynecol Scand; 2023 Mar; 102(3):240-245. PubMed ID: 36645194
[TBL] [Abstract] [Full Text] [Related]
6. Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy for ovarian cancer Prevention: A Cost-effectiveness Analysis.
Matsuo K; Chen L; Matsuzaki S; Mandelbaum RS; Ciesielski KM; Silva JP; Klar M; Roman LD; Accordino MK; Melamed A; Elkin E; Hershman DL; Wright JD
Ann Surg; 2023 May; 277(5):e1116-e1123. PubMed ID: 35129467
[TBL] [Abstract] [Full Text] [Related]
7. BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories.
Hovland HN; Al-Adhami R; Ariansen SL; Van Ghelue M; Sjursen W; Lima S; Bolstad M; Berger AH; Høberg-Vetti H; Knappskog P; Haukanes BI; Aukrust I; Ognedal E
Fam Cancer; 2022 Oct; 21(4):389-398. PubMed ID: 34981296
[TBL] [Abstract] [Full Text] [Related]
8. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract] [Full Text] [Related]
9. Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
Perri T; Levin G; Naor-Revel S; Eliassi-Revivo P; Lifshitz D; Friedman E; Korach J
Int J Gynaecol Obstet; 2022 May; 157(2):431-436. PubMed ID: 34324701
[TBL] [Abstract] [Full Text] [Related]
10. Is complete mesocolic excision or total mesorectal excision necessary during cytoreductive surgery in ovarian peritoneal carcinomatosis with colonic involvement?
Karadayi K; Karabacak U
Acta Chir Belg; 2023 Apr; 123(2):124-131. PubMed ID: 34253150
[TBL] [Abstract] [Full Text] [Related]
11. Menin‑MLL inhibitors induce ferroptosis and enhance the anti‑proliferative activity of auranofin in several types of cancer cells.
Kato I; Kasukabe T; Kumakura S
Int J Oncol; 2020 Oct; 57(4):1057-1071. PubMed ID: 32945449
[TBL] [Abstract] [Full Text] [Related]
12. Increased Malignancy Rate in Children With IgE Deficiency: A Single-center Experience.
Ferastraoaru D; Schwartz D; Rosenstreich D
J Pediatr Hematol Oncol; 2021 May; 43(4):e472-e477. PubMed ID: 32769562
[TBL] [Abstract] [Full Text] [Related]
13. Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.
Mittempergher L; Piskorz AM; Bosma AJ; Michaut M; Wisman GBA; Kluin RJC; Nieuwland M; Brugman W; van der Ven KJW; Marass F; Morris J; Rosenfeld N; Jimenez-Linan M; de Jong S; van der Zee AGJ; Brenton JD; Bernards R
PLoS One; 2020; 15(7):e0235766. PubMed ID: 32639993
[TBL] [Abstract] [Full Text] [Related]
14. Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.
Tanabe Y; Shiraishi S; Hashimoto K; Ikeda K; Nishizawa D; Hasegawa J; Shimomura A; Ozaki Y; Tamura N; Yunokawa M; Yonemori K; Takano T; Kawabata H; Tamura K; Fujiwara Y; Shimizu C
BMC Cancer; 2020 Apr; 20(1):325. PubMed ID: 32295642
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of radiological recurrence patterns in ovarian cancer.
Roze JF; Veldhuis WB; Hoogendam JP; Verheijen RHM; Scholten RJPM; Zweemer RP
Gynecol Oncol; 2020 Jun; 157(3):606-612. PubMed ID: 32171567
[TBL] [Abstract] [Full Text] [Related]
16. The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
Lenck C; Chopin N; Gouy S; Bonsang-Kitzis H; Martinez-Gomez C; Radosevic-Robin N; Martin S; Lefeuvre-Plesse C; Lambaudie E; Leblanc E; Guyon F; Classe JM; Ramanah R; Beurrier F; Angeles MA; Pomel C; Joly F; de la Motte Rouge T; Provansal M; Lesoin A; Floquet A; Berton D; Kalbacher E; Chakiba C; Meeus P; Selle F; Treilleux I; Lecuru F; Pautier P; Ray-Coquard I
Gynecol Oncol; 2020 Apr; 157(1):78-84. PubMed ID: 32131977
[TBL] [Abstract] [Full Text] [Related]
17. Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells.
Valinezhad Sani F; Palizban A; Mosaffa F; Jamialahmadi K
Eur J Pharmacol; 2020 Feb; 868():172883. PubMed ID: 31866406
[TBL] [Abstract] [Full Text] [Related]
18. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
Liao YM; Song Y; Li YK; Du JH; Zhou Y
Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
[TBL] [Abstract] [Full Text] [Related]
19. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Moore KN; Secord AA; Geller MA; Miller DS; Cloven N; Fleming GF; Wahner Hendrickson AE; Azodi M; DiSilvestro P; Oza AM; Cristea M; Berek JS; Chan JK; Rimel BJ; Matei DE; Li Y; Sun K; Luptakova K; Matulonis UA; Monk BJ
Lancet Oncol; 2019 May; 20(5):636-648. PubMed ID: 30948273
[TBL] [Abstract] [Full Text] [Related]
20. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
Zhang L; Luo M; Yang H; Zhu S; Cheng X; Qing C
J Ovarian Res; 2019 Feb; 12(1):19. PubMed ID: 30786925
[TBL] [Abstract] [Full Text] [Related]
[Next]
